Open AccessNUCLEOSIDE ANALOG FAVIPIRAVIR IS A POOR INHIBITOR AGAINST THE SARS-COV-2 VIRUS IN CELL CULTURE, BUT FAVIPIRAVIR IS HIGHLY ACTIVE AGAINST VENEZUELAN EQUINE ENCEPHALITIS VIRUS
Author(s) -
G.M. Zauatbayeva,
L.R. Syzdykova,
Viktoriya Keyer,
A.V. Shustov,
A.Z. Abilmagzhanov,
M.Zh. Zhurynov
Publication year - 2022
Publication title -
eurasian journal of applied biotechnology
Language(s) - English
Resource type - Journals
eISSN - 2617-1147
pISSN - 2617-1139
DOI - 10.11134/btp.2.2022.7
Subject(s) - favipiravir , virology , venezuelan equine encephalitis virus , virus , rna , vero cell , biology , rna virus , viral replication , nucleoside analogue , coronavirus , antiviral drug , alphavirus , nucleoside , medicine , covid-19 , biochemistry , disease , infectious disease (medical specialty) , pathology , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom